Upcoming Webinars

Upcoming Webinars

September 27, 2017 2:00 pm to 3:00 pm EDT

Chronic wounds, or wounds that fail to proceed through an orderly and timely repair process, affect some 6.5 million patients in the United States with an associated cost of care over $50 billion annually. These ailments can require lengthy treatments at significant costs to the healthcare system. Major disability, poor quality of life, and reduced productivity contribute to the growing financial burden. The number of people affected by a chronic wound is expected to increase as the population ages and the incidence of diabetes and obesity continues to rise worldwide. Wound duration is an independent risk factor for infection, hospitalization, and amputation, and contributes to patient morbidity, mortality, and cost of care.

Osiris Therapeutics, Inc. is committed to developing regenerative medicine products that provide better solutions to address the unmet needs of hard-to-treat wounds, including diabetic foot ulcers and venous leg ulcers. Osiris's proprietary manufacturing process retains the native characteristics and inherent functionality of placental tissue, a tissue that has been used in the wound care space for over 100 years. The results are safe, easy-to-use products that have been shown to be beneficial in supporting natural wound repair and decreasing the time it takes to close chronic wounds.


  • Describe the science of placental membranes and their relevance in chronic and complex wounds
  • Review published clinical study results on the use of placental membranes in complex wounds with exposed bone and tendons
  • Explore clinical case studies on the use of placental membranes in a variety of chronic and complex wounds

On-Demand Webinars

  • Up to 45% of hospital-acquired pressure ulcers/injuries occur in the surgical population and the numbers for ICU are at a 10% average.1,2 Interventions to reduce hospital-acquired pressure ulcers/injuries are readily available. However, implementing a comprehensive prevention program that becomes part of the culture can be an arduous endeavor. Please join us to learn how two clinicians lead respective teams to implement protocols and processes to drive pressure ulcer/injury reduction, lower costs and establish the practice as part of their culture.

    Molly Sammon will discuss risk factors identified among patients at the Heart and Vascular Institute; interventions to reduce hospital-acquired pressure ulcers/injuries and associated costs; and share their practices for a culture of pressure ulcer/injury prevention. Peggy O’Harra will share practices and results from a comprehensive pressure ulcer/injury prevention plan for the OR/ICU and how that plan was implemented throughout an eight-hospital system.

  • A strong knowledge of moisture-associated skin damage (MASD) will help clinicians in the assessment, prevention and treatment of the various types of moisture related skin injuries. This webinar will provide clinicians with foundational knowledge to support the overall management goals of caring for a person with MASD, or who may be at risk of developing skin injuries due to moisture causes.

  • Join Tissue Analytics, a leader in advanced wound documentation, for a discussion on: Wound measurement techniques, new trends and upcoming changes to quality reporting requirements, automated documentation tools, population-level management using real-time data, and how analytics can speed up your workflow – and save you time.

  • Be ready to learn about the types of tissue that may impede wound healing, methods of debridement, levels of microorganisms found in a wound bed, the definition of biofilm, and other important factors in wound bed management.